Go Pro

B Group, Inc. Top Holdings and 13F Report (2026)

About B Group, Inc.

Investment Activity

  • B Group, Inc. has $213.01 million in total holdings as of June 30, 2026.
  • B Group, Inc. owns shares of 19 different stocks, but just 11 companies or ETFs make up 80% of its holdings.
  • Approximately 27.85% of the portfolio was purchased this quarter.
  • About 1.76% of the portfolio was sold this quarter.
  • This quarter, B Group, Inc. has purchased 20 new stocks and bought additional shares in 5 stocks.
  • B Group, Inc. sold shares of 1 stock and completely divested from 3 stocks this quarter.

Largest Holdings

INVESCO QQQ TR
$36,820,000
ADMA Biologics
$27,307,477
PALISADE BIO INC
$23,855,856
NRX PHARMACEUTICALS INC
$16,735,327
FAETH THERAPEUTICS INC
$15,254,225

Largest New Holdings this Quarter

46090E953 - INVESCO QQQ TR
$36,820,000 Holding
81728A207 - FAETH THERAPEUTICS INC
$15,254,225 Holding

Largest Purchases this Quarter

INVESCO QQQ TR
50,000 shares (about $36.82M)
FAETH THERAPEUTICS INC
610,169 shares (about $15.25M)
NRX PHARMACEUTICALS INC
1,091,767 shares (about $4.47M)
Aura Biosciences
166,667 shares (about $1.18M)
Structure Therapeutics
12,500 shares (about $670.88K)

Largest Sales this Quarter

SPYRE THERAPEUTICS INC
30,000 shares (about $2.66M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofB Group, Inc.

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
INVESCO QQQ TR
$36,820,000$36,820,000 â–²New Holding50,00017.3%PUT
ADMA Biologics Inc stock logo
ADMA
ADMA Biologics
$27,307,477$460,350 â–²1.7%3,262,54212.8%Healthcare
PALISADE BIO INC
$23,855,8560.0%11,414,28511.2%COM
NRX PHARMACEUTICALS INC
$16,735,327$4,465,327 â–²36.4%4,091,7677.9%COM NEW
FAETH THERAPEUTICS INC
$15,254,225$15,254,225 â–²New Holding610,1697.2%COM NEW
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$12,261,7860.0%1,800,5565.8%Healthcare
PRAXIS PRECISION MEDICINES I
$11,127,4150.0%33,2375.2%COM NEW
Cellectis S.A. stock logo
CLLS
Cellectis
$9,844,5030.0%3,281,5014.6%Healthcare
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
$8,562,2740.0%450,6464.0%Healthcare
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
$7,513,800$670,875 â–²9.8%140,0003.5%Healthcare
ORUKA THERAPEUTICS INC
$7,137,7500.0%75,0003.4%COM
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$6,240,0000.0%1,500,0002.9%Healthcare
SPYRE THERAPEUTICS INC
$6,214,600$2,663,400 â–¼-30.0%70,0002.9%COM NEW
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
$5,426,125$1,183,336 â–²27.9%764,2432.5%Healthcare
ASSEMBLY BIOSCIENCES INC
$4,828,4010.0%175,7062.3%COM NEW
BRIGHT MINDS BIOSCIENCES INC
$4,738,5000.0%67,5002.2%COM NEW
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
$4,507,6500.0%135,0002.1%Healthcare
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$3,656,9000.0%970,0001.7%Healthcare
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
$976,000$478,240 â–²96.1%200,0000.5%Healthcare
APOGEE THERAPEUTICS INC
$0$631,275 â–¼-100.0%00.0%COM
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$0$251,100 â–¼-100.0%00.0%Healthcare
Replimune Group, Inc. stock logo
REPL
Replimune Group
$0$198,900 â–¼-100.0%00.0%Healthcare

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data